Strategic Global Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,901
Closed -$301K 169
2020
Q3
$301K Sell
2,901
-26,413
-90% -$2.65M 0.06% 138
2020
Q2
$2.69M Buy
29,314
+2,470
+9% +$237K 0.57% 52
2020
Q1
$2.42M Buy
26,844
+12,341
+85% +$1.31M 0.62% 48
2019
Q4
$1.65M Sell
14,503
-53
-0.4% -$5.82K 0.34% 79
2019
Q3
$1.58M Sell
14,556
-15,239
-51% -$1.59M 0.36% 77
2019
Q2
$2.9M Sell
29,795
-1,434
-5% -$131K 0.62% 46
2019
Q1
$2.84M Buy
31,229
+27,486
+734% +$2.46M 0.6% 54
2018
Q4
$340K Buy
+3,743
New +$350K 0.12% 126
2016
Q1
Sell
-33,796
Closed -$2.6M 152
2015
Q4
$2.6M Buy
33,796
+84
+0.2% +$6.32K 1.11% 25
2015
Q3
$2.26M Buy
33,712
+2,501
+8% +$184K 1.08% 32
2015
Q2
$2.31M Buy
31,211
+4,850
+18% +$371K 1.35% 9
2015
Q1
$2.06M Buy
+26,361
New +$2M 1.52% 8

Other funds holding MDT

Strategic Global Advisors's MDT Position: Q4 2020 in Review

Strategic Global Advisors sold out of Medtronic (MDT) in Q4 2020, closing a stake of 2,901 shares — an estimated $301K sold.

Strategic Global Advisors first reported a position in MDT in Q1 2015 and held it in 12 quarters. The position peaked at $2.9M in Q2 2019. 1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

  • Strategic Global Advisors reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
  • Strategic Global Advisors sold 2,901 Medtronic shares in Q4 2020, an estimated $301K.
  • Strategic Global Advisors first reported a position in Medtronic in Q1 2015 and held it in 12 quarters.
  • Strategic Global Advisors's Medtronic position peaked at $2.9M in Q2 2019.
  • 1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Strategic Global Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.